TRIAMCINOLONE ACETONIDE aerosol, spray

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Achète-le

Ingrédients actifs:

TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA)

Disponible depuis:

Padagis Israel Pharmaceuticals Ltd

DCI (Dénomination commune internationale):

TRIAMCINOLONE ACETONIDE

Composition:

TRIAMCINOLONE ACETONIDE 0.147 mg in 1 g

Mode d'administration:

TOPICAL

Type d'ordonnance:

PRESCRIPTION DRUG

indications thérapeutiques:

Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.

Descriptif du produit:

Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g 63 g (NDC 45802-045 -01) aerosol can. 100 g (NDC 45802-045 -02) aerosol can.

Statut de autorisation:

Abbreviated New Drug Application

Résumé des caractéristiques du produit

                                TRIAMCINOLONE ACETONIDE- TRIAMCINOLONE ACETONIDE AEROSOL, SPRAY
PADAGIS ISRAEL PHARMACEUTICALS LTD
----------
TRIAMCINOLONE ACETONIDE TOPICAL AEROSOL USP, 0.147 MG/G
RX ONLY
FOR DERMATOLOGIC USE ONLY
NOT FOR OPHTHALMIC USE
DESCRIPTION
The topical corticosteroids constitute a class of primarily synthetic
steroids used as anti-
inflammatory and antipruritic agents. The steroids in this class
include triamcinolone
acetonide. Triamcinolone acetonide is designated chemically as
9-fluoro-11β, 16α, 17,
21-tetrahydroxypregna-1, 4-diene-3, 20-dione cyclic 16, 17-acetal with
acetone. The
structural formula is:
A two-second application, which covers an area approximately the size
of the hand,
delivers an amount of triamcinolone acetonide not exceeding 0.2 mg.
After spraying, the
nonvolatile vehicle remaining on the skin contains approximately 0.2%
triamcinolone
acetonide. Each gram of spray provides 0.147 mg triamcinolone
acetonide in a vehicle of
isopropyl palmitate, dehydrated alcohol (10.3%), and isobutane
propellant.
CLINICAL PHARMACOLOGY
Topical corticosteroids share anti-inflammatory, antipruritic and
vasoconstrictive actions.
The mechanism of anti-inflammatory activity of the topical
corticosteroids is unclear.
Various laboratory methods, including vasoconstrictor assays, are used
to compare and
predict potencies and/or clinical efficacies of the topical
corticosteroids. There is some
evidence to suggest that a recognizable correlation exists between
vasoconstrictor
potency and therapeutic efficacy in man.
PHARMACOKINETICS
The extent of percutaneous absorption of topical corticosteroids is
determined by many
factors including the vehicle, the integrity of the epidermal barrier,
and the use of
occlusive dressings.
Topical corticosteroids can be absorbed from normal intact skin.
Inflammation and/or
other disease processes in the skin increase percutaneous absorption.
Once absorbed through the skin, topical corticosteroids are handled
through
pharmacokinetic pathways similar to systemically administered
corticosteroid
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit